An appetite for growth: Pharmacy’s big bet on GLP-1s

GLP-1s have provided a financial boost to pharmacies, but patients ineligible for subsidies say the cost of the medicines is often prohibitive. Kate Cowling reports on how the market is evolving—and what we can expect next Weight loss medicines have exploded in popularity in the past couple of years, leading to top line growth for